fda category 2 bulk drug substances bpc 157 compounding list An advisory committee voted Thursday to remove restrictions on four peptides despite little evidence the products are safe or effective for medical use. In a series of 8-6 votes (with This just in: The FDA
This just in: The FDA is proposing to move 14 commonly used peptides from Category 2 to Category 1 on the compounding review list If finalized, this shift could significantly change FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner Updated 2026 FDA Category 2 peptide list As the science and regulations continue to develop, it's important to work with providers who stay informed and prioritize safe, medically guided protocols. At FDA Set to Review Peptide Access for Compounding Pharmacies Drug Topics
Pay in 4 interest-free payments of $5.92 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10

